TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2020 DA - 2020// TI - Cancer statistics, 2020. JO - CA VL - 70 ID - Siegel2020 ER - TY - STD TI - Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 2018;68: 394–424. ID - ref2 ER - TY - JOUR AU - Roncucci, L. AU - Mariani, F. PY - 2015 DA - 2015// TI - Prevention of colorectal cancer: How many tools do we have in our basket? JO - Eur J Intern Med VL - 26 UR - https://doi.org/10.1016/j.ejim.2015.08.019 DO - 10.1016/j.ejim.2015.08.019 ID - Roncucci2015 ER - TY - JOUR AU - Dekker, E. AU - Tanis, P. J. AU - Vleugels, J. L. A. AU - Kasi, P. M. AU - Wallace, M. B. PY - 2019 DA - 2019// TI - Colorectal cancer JO - The Lancet VL - 394 UR - https://doi.org/10.1016/S0140-6736(19)32319-0 DO - 10.1016/S0140-6736(19)32319-0 ID - Dekker2019 ER - TY - JOUR AU - Piawah, S. AU - Venook, A. P. PY - 2019 DA - 2019// TI - Targeted therapy for colorectal cancer metastases: a review of current methods of molecularly targeted therapy and the use of tumor biomarkers in the treatment of metastatic colorectal cancer JO - Cancer-Am Cancer Soc VL - 125 ID - Piawah2019 ER - TY - JOUR AU - Katona, B. W. AU - Weiss, J. M. PY - 2020 DA - 2020// TI - Chemoprevention of Colorectal Cancer JO - Gastroenterology VL - 158 UR - https://doi.org/10.1053/j.gastro.2019.06.047 DO - 10.1053/j.gastro.2019.06.047 ID - Katona2020 ER - TY - JOUR AU - Keum, N. AU - Giovannucci, E. PY - 2019 DA - 2019// TI - Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies JO - Nat Rev Gastro Hepat VL - 16 UR - https://doi.org/10.1038/s41575-019-0189-8 DO - 10.1038/s41575-019-0189-8 ID - Keum2019 ER - TY - JOUR AU - Farhan, H. AU - Hsu, V. PY - 2015 DA - 2015// TI - Cdc42 and cellular polarity: emerging roles at the golgi JO - Trends Cell Biol VL - 26 UR - https://doi.org/10.1016/j.tcb.2015.11.003 DO - 10.1016/j.tcb.2015.11.003 ID - Farhan2015 ER - TY - JOUR AU - Maldonado-Montalban, M. D. M. AU - Dharmawardhane, S. PY - 2018 DA - 2018// TI - Targeting Rac and Cdc42 GTPases in Cancer JO - Cancer Res. VL - 78 UR - https://doi.org/10.1158/0008-5472.CAN-18-0619 DO - 10.1158/0008-5472.CAN-18-0619 ID - Maldonado-Montalban2018 ER - TY - JOUR AU - Yang, D. AU - Zhang, Y. AU - Cheng, Y. AU - Hong, L. AU - Wang, C. AU - Wei, Z. AU - Cai, Q. AU - Yan, R. PY - 2017 DA - 2017// TI - High Expression of cell division cycle 42 promotes pancreatic cancer growth and predicts poor outcome of pancreatic cancer patients JO - Dig Dis Sci VL - 62 UR - https://doi.org/10.1007/s10620-017-4451-z DO - 10.1007/s10620-017-4451-z ID - Yang2017 ER - TY - JOUR AU - Dong, Z. AU - Yu, C. AU - Rezhiya, K. AU - Gulijiahan, A. AU - Wang, X. PY - 2019 DA - 2019// TI - Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway JO - Artif Cells Nanomed Biotechnol VL - 47 UR - https://doi.org/10.1080/21691401.2019.1664560 DO - 10.1080/21691401.2019.1664560 ID - Dong2019 ER - TY - JOUR AU - Li, X. AU - Jiang, M. AU - Chen, D. AU - Xu, B. AU - Wang, R. AU - Chu, Y. AU - Wang, W. AU - Zhou, L. AU - Lei, Z. AU - Nie, Y. AU - Fan, D. AU - Shang, Y. AU - Wu, K. AU - Liang, J. PY - 2018 DA - 2018// TI - MiR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis JO - J Exp Clin Canc Res VL - 37 UR - https://doi.org/10.1186/s13046-018-0729-z DO - 10.1186/s13046-018-0729-z ID - Li2018 ER - TY - JOUR AU - Farrugia, A. J. AU - Calvo, F. PY - 2017 DA - 2017// TI - Cdc42 regulates Cdc42EP3 function in cancer-associated fibroblasts JO - Small GTPases VL - 8 UR - https://doi.org/10.1080/21541248.2016.1194952 DO - 10.1080/21541248.2016.1194952 ID - Farrugia2017 ER - TY - JOUR AU - Eduardo Da Silva, L. AU - Russo, L. C. AU - Forti, F. L. PY - 2020 DA - 2020// TI - Overactivated Cdc42 acts through Cdc42EP3/Borg2 and NCK to trigger DNA damage response signaling and sensitize cells to DNA-damaging agents JO - Exp Cell Res VL - 395 UR - https://doi.org/10.1016/j.yexcr.2020.112206 DO - 10.1016/j.yexcr.2020.112206 ID - Eduardo Da Silva2020 ER - TY - JOUR AU - Calvo, F. AU - Ranftl, R. AU - Hooper, S. AU - Farrugia, A. J. AU - Moeendarbary, E. AU - Bruckbauer, A. AU - Batista, F. AU - Charras, G. AU - Sahai, E. PY - 2015 DA - 2015// TI - Cdc42EP3/BORG2 and septin network enables mechano-transduction and the emergence of cancer-associated fibroblasts JO - Cell Rep VL - 13 UR - https://doi.org/10.1016/j.celrep.2015.11.052 DO - 10.1016/j.celrep.2015.11.052 ID - Calvo2015 ER - TY - JOUR AU - Valdésmora, F. AU - Locke, W. J. AU - Bandrés, E. AU - Gallegoortega, D. AU - Cejas, P. AU - Garcíacabezas, M. A. AU - Colinosanguino, Y. AU - Feliú, J. AU - Pulgar, T. G. AU - Lacal, J. C. PY - 2017 DA - 2017// TI - Clinical relevance of the transcriptional signature regulated by CDC42 in colorectal cancer JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.15815 DO - 10.18632/oncotarget.15815 ID - Valdésmora2017 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2019 DA - 2019// TI - Cancer statistics, 2019 JO - CA VL - 69 ID - Siegel2019 ER - TY - JOUR AU - Weitz, J. AU - Koch, M. AU - Debus, J. AU - Höhler, T. AU - Galle, P. R. AU - Büchler, M. W. PY - 2005 DA - 2005// TI - Colorectal cancer JO - Lancet VL - 365 UR - https://doi.org/10.1016/S0140-6736(05)17706-X DO - 10.1016/S0140-6736(05)17706-X ID - Weitz2005 ER - TY - JOUR AU - Saltz, L. B. PY - 2016 DA - 2016// TI - Value in Colorectal Cancer Treatment: Where It Is Lacking, and Why JO - Cancer J VL - 22 UR - https://doi.org/10.1097/PPO.0000000000000194 DO - 10.1097/PPO.0000000000000194 ID - Saltz2016 ER - TY - JOUR AU - Geng, F. AU - Wang, Z. AU - Yin, H. AU - Yu, J. AU - Cao, B. PY - 2017 DA - 2017// TI - Molecular targeted drugs and treatment of colorectal cancer: recent progress and future perspectives JO - Cancer Biother Radiopharm VL - 32 ID - Geng2017 ER - TY - JOUR AU - Mody, K. AU - Baldeo, C. AU - Bekaii-Saab, T. PY - 2018 DA - 2018// TI - Antiangiogenic therapy in colorectal cancer JO - Cancer J VL - 24 UR - https://doi.org/10.1097/PPO.0000000000000328 DO - 10.1097/PPO.0000000000000328 ID - Mody2018 ER - TY - JOUR AU - Miyamoto, Y. AU - Suyama, K. AU - Baba, H. PY - 2017 DA - 2017// TI - Recent advances in targeting the EGFR signaling pathway for the treatment of metastatic colorectal cancer JO - Int J Mol Sci VL - 18 UR - https://doi.org/10.3390/ijms18040752 DO - 10.3390/ijms18040752 ID - Miyamoto2017 ER - TY - JOUR AU - Wang, X. AU - Lan, Z. AU - He, J. AU - Lai, Q. AU - Yao, X. AU - Li, Q. AU - Liu, Y. AU - Lai, H. AU - Gu, C. AU - Yan, Q. AU - Fang, Y. AU - Zhang, Y. AU - Li, A. AU - Liu, S. PY - 2019 DA - 2019// TI - LncRNA SNHG6 promotes chemoresistance through ULK1-induced autophagy by sponging miR-26a-5p in colorectal cancer cells JO - Cancer Cell Int VL - 19 UR - https://doi.org/10.1186/s12935-019-0951-6 DO - 10.1186/s12935-019-0951-6 ID - Wang2019 ER - TY - JOUR AU - Chen, C. AU - Su, L. AU - Tsai, H. AU - Hwang, C. PY - 2019 DA - 2019// TI - ELF-1 expression in nasopharyngeal carcinoma facilitates proliferation and metastasis of cancer cells via modulation of CCL2/CCR2 signaling JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S196355 DO - 10.2147/CMAR.S196355 ID - Chen2019 ER - TY - JOUR AU - Wu, H. AU - Zou, Q. AU - He, H. AU - Liang, Y. AU - Lei, M. AU - Zhou, Q. AU - Fan, D. AU - Shen, L. PY - 2019 DA - 2019// TI - Long non-coding RNA PCAT6 targets miR-204 to modulate the chemoresistance of colorectal cancer cells to 5-fluorouracil-based treatment through HMGA2 signaling JO - Cancer Med. VL - 8 UR - https://doi.org/10.1002/cam4.1809 DO - 10.1002/cam4.1809 ID - Wu2019 ER - TY - JOUR AU - Stankiewicz, T. AU - Linseman, D. PY - 2014 DA - 2014// TI - Rho family GTPases: Key players in neuronal development, neuronal survival, and neurodegeneration JO - Front Cell Neurosci VL - 8 UR - https://doi.org/10.3389/fncel.2014.00314 DO - 10.3389/fncel.2014.00314 ID - Stankiewicz2014 ER - TY - JOUR AU - Williams, M. J. PY - 2012 DA - 2012// TI - Rho GTPases central regulators of cell migration JO - Small GTPases VL - 3 UR - https://doi.org/10.4161/sgtp.20335 DO - 10.4161/sgtp.20335 ID - Williams2012 ER - TY - JOUR AU - Fukata, M. AU - Nakagawa, M. AU - Kaibuchi, K. PY - 2003 DA - 2003// TI - Roles of Rho-family GTPases in cell polarisation and directional migration JO - Curr Opin Cell Biol VL - 15 UR - https://doi.org/10.1016/S0955-0674(03)00097-8 DO - 10.1016/S0955-0674(03)00097-8 ID - Fukata2003 ER - TY - JOUR AU - Razidlo, G. L. AU - Burton, K. M. AU - McNiven, M. A. PY - 2018 DA - 2018// TI - Interleukin-6 promotes pancreatic cancer cell migration by rapidly activating the small GTPase CDC42 JO - J Biol Chem VL - 293 UR - https://doi.org/10.1074/jbc.RA118.003276 DO - 10.1074/jbc.RA118.003276 ID - Razidlo2018 ER - TY - JOUR AU - Xiao, X. AU - Lv, L. AU - Duan, J. AU - Wu, Y. AU - He, S. AU - Hu, Z. AU - Xiong, L. PY - 2018 DA - 2018// TI - Regulating Cdc42 and Its Signaling Pathways in Cancer: Small Molecules and MicroRNA as New Treatment Candidates JO - Molecules VL - 23 UR - https://doi.org/10.3390/molecules23040787 DO - 10.3390/molecules23040787 ID - Xiao2018 ER - TY - JOUR AU - Hirsch, D. S. AU - Pirone, D. M. AU - Burbelo, P. D. PY - 2001 DA - 2001// TI - A new family of Cdc42 effector proteins, CEPs, function in fibroblast and epithelial cell shape changes JO - J Biol Chem VL - 276 UR - https://doi.org/10.1074/jbc.M007039200 DO - 10.1074/jbc.M007039200 ID - Hirsch2001 ER - TY - JOUR AU - Joberty, G. AU - Perlungher, R. R. AU - Macara, I. G. PY - 1999 DA - 1999// TI - The Borgs, a new family of Cdc42 and TC10 GTPase-interacting proteins JO - Mol Cell Biol VL - 19 UR - https://doi.org/10.1128/MCB.19.10.6585 DO - 10.1128/MCB.19.10.6585 ID - Joberty1999 ER - TY - JOUR AU - Diepenbruck, M. AU - Christofori, G. PY - 2016 DA - 2016// TI - Epithelial-mesenchymal transition (EMT) and metastasis: yes, no, maybe? JO - Curr Opin Cell Biol VL - 43 UR - https://doi.org/10.1016/j.ceb.2016.06.002 DO - 10.1016/j.ceb.2016.06.002 ID - Diepenbruck2016 ER - TY - JOUR AU - Samy, L. AU - Jian, X. AU - Rik, D. PY - 2014 DA - 2014// TI - Molecular mechanisms of epithelial-mesenchymal transition JO - Nat Rev Mol Cell Bio VL - 15 UR - https://doi.org/10.1038/nrm3758 DO - 10.1038/nrm3758 ID - Samy2014 ER - TY - JOUR AU - Loh, C. Y. AU - Chai, J. Y. AU - Tang, T. F. AU - Wong, W. F. AU - Sethi, G. PY - 2019 DA - 2019// TI - The E-Cadherin and N-Cadherin switch in epithelial-to-mesenchymal transition: signaling, therapeutic implications, and challenges JO - Cells-Basel VL - 8 UR - https://doi.org/10.3390/cells8101118 DO - 10.3390/cells8101118 ID - Loh2019 ER - TY - JOUR AU - Zhu, Z. AU - Rong, Z. AU - Luo, Z. AU - Yu, Z. AU - Zhang, J. AU - Qiu, Z. AU - Huang, C. PY - 2019 DA - 2019// TI - Circular RNA circNHSL1 promotes gastric cancer progression through the miR-1306-3p/SIX1/vimentin axis JO - Mol Cancer VL - 18 UR - https://doi.org/10.1186/s12943-019-1054-7 DO - 10.1186/s12943-019-1054-7 ID - Zhu2019 ER - TY - JOUR AU - Ye, Y. AU - Huang, S. AU - Wu, Y. PY - 2019 DA - 2019// TI - UNBS5162 and amonafide inhibits tumor progression in human melanoma by the AKT/mTOR pathway JO - Cancer Manag Res VL - 11 UR - https://doi.org/10.2147/CMAR.S177623 DO - 10.2147/CMAR.S177623 ID - Ye2019 ER - TY - JOUR AU - Wei, C. AU - Wang, L. AU - Zhu, M. AU - Deng, X. AU - Wang, D. AU - Zhang, S. AU - Ying, J. AU - Yuan, X. AU - Wang, Q. AU - Xuan, T. AU - He, A. AU - Qi, F. AU - Gu, J. PY - 2019 DA - 2019// TI - TRIM44 activates the AKT/mTOR signal pathway to induce melanoma progression by stabilizing TLR4 JO - J Exp Clin Canc Res VL - 38 UR - https://doi.org/10.1186/s13046-019-1138-7 DO - 10.1186/s13046-019-1138-7 ID - Wei2019 ER - TY - JOUR AU - Wan, G. AU - Liu, Y. AU - Zhu, J. AU - Guo, L. AU - Li, C. AU - Yang, Y. AU - Gu, X. AU - Deng, L. AU - Lu, C. PY - 2019 DA - 2019// TI - SLFN5 suppresses cancer cell migration and invasion by inhibiting MT1-MMP expression via AKT/GSK-3β/β-catenin pathway JO - Cell Signal VL - 59 UR - https://doi.org/10.1016/j.cellsig.2019.03.004 DO - 10.1016/j.cellsig.2019.03.004 ID - Wan2019 ER - TY - JOUR AU - Qie, S. AU - Diehl, J. A. PY - 2016 DA - 2016// TI - Cyclin D1, cancer progression, and opportunities in cancer treatment JO - J Mol Med VL - 94 UR - https://doi.org/10.1007/s00109-016-1475-3 DO - 10.1007/s00109-016-1475-3 ID - Qie2016 ER - TY - JOUR AU - Tigan, A. AU - Bellutti, F. AU - Kollmann, K. AU - Tebb, G. AU - Sexl, V. PY - 2015 DA - 2015// TI - CDK6—a review of the past and a glimpse into the future: from cell-cycle control to transcriptional regulation JO - Oncogene VL - 35 UR - https://doi.org/10.1038/onc.2015.407 DO - 10.1038/onc.2015.407 ID - Tigan2015 ER - TY - JOUR AU - Chen, M. J. AU - Cheng, A. C. AU - Lee, M. F. AU - Hsu, Y. C. PY - 2017 DA - 2017// TI - Simvastatin induces G1 arrest by up-regulating GSK3β and down-regulating CDK4/cyclin D1 and CDK2/cyclin E1 in human primary colorectal cancer cells JO - J Cell Physiol VL - 233 UR - https://doi.org/10.1002/jcp.26156 DO - 10.1002/jcp.26156 ID - Chen2017 ER - TY - JOUR AU - Liu, J. Y. AU - Wu, X. Y. AU - Wu, G. N. AU - Liu, F. AU - Yao, X. PY - 2017 DA - 2017// TI - FOXQ1 promotes cancer metastasis by PI3K/AKT signaling regulation in colorectal carcinoma JO - Am J Transl Res VL - 9 ID - Liu2017 ER - TY - JOUR AU - Irvine, M. AU - Stewart, A. AU - Pedersen, B. AU - Boyd, S. AU - Kefford, R. AU - Rizos, H. PY - 2018 DA - 2018// TI - Oncogenic PI3K/AKT promotes the step-wise evolution of combination BRAF/MEK inhibitor resistance in melanoma JO - Oncogenesis VL - 7 UR - https://doi.org/10.1038/s41389-018-0081-3 DO - 10.1038/s41389-018-0081-3 ID - Irvine2018 ER -